UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026862
Receipt number R000030826
Scientific Title Hypoxia imaging in the brain and spinal cord of ALS
Date of disclosure of the study information 2017/04/05
Last modified on 2019/04/06 15:08:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hypoxia imaging in the brain and spinal cord of ALS

Acronym

Hypoxia imaging in the brain and spinal cord of ALS

Scientific Title

Hypoxia imaging in the brain and spinal cord of ALS

Scientific Title:Acronym

Hypoxia imaging in the brain and spinal cord of ALS

Region

Japan


Condition

Condition

neurological diseases

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the hypoxic stress by FMISO PET in the brain and spinal cord of ALS

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Evaluate the hypoxic stress by FMISO PET in the brain and spinal cord of ALS

Key secondary outcomes

Evaluate the relationship between physical function or clinical test results and FMISO PET results


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

18F-fluoromisonidazole; FMISO

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

ALS patients who are in hospital or hospitalized at Okayama University Hospital and are able to communicate in Japanese

Key exclusion criteria

In the case that the Research Director or the Research Assignee certifies that it is not suitable for registration

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koji Abe

Organization

Okayama university, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Neurology

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7365

Email

yasuyuki@okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuyuki Ohta

Organization

Okayama university hospital

Division name

Neurology

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7365

Homepage URL


Email

yasuyuki@okayama-u.ac.jp


Sponsor or person

Institute

Okayama university

Institute

Department

Personal name



Funding Source

Organization

Okayama university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 05 Day

Date of IRB

2017 Year 05 Month 01 Day

Anticipated trial start date

2017 Year 05 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 04 Month 04 Day

Last modified on

2019 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030826


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name